MK-0616
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-0616, covering 2024-09-19 to 2024-10-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016) [Phase 1]